IGF1 and Hepatic fibrosis: Their findings revealed that extracellular vesicles (EVs) derived from IGF‐I‐modified MSCs exerted stronger anti‐fibrotic effects in a thioacetamide‐induced liver fibrosis model compared to EV‐depleted conditioned medium.